A popular, growing class of drugs for obesity and diabetes could, in an ideal world, help us see that metabolism and appetite are biological facts, not moral choices.
“It’s extremely important we as health care professionals address diabetes, poor sleep and poor sleep hygiene, and obesity as they are modifiable risk factors for cardiovascular disease,” says Nishant P. Shah, MD, FACC, a preventive cardiologist at Duke Heart Center, Duke University School of Medicine, in Durham, NC.
Obesity, diabetes and sleep-disordered breathing (SDB) are considered to be extant and growing public health crises. A wealth of information links these conditions to each other and to increased morbidity, reduced quality of life and death. While managing these conditions that often occur together may be challenging for patients and clinicians, successfully addressing them represents a real opportunity to reduce cardiovascular disease and prevent cardiovascular events.
March 6, 2023: A selection of three essential articles read aloud from the latest issue of The Economist. This week, how to cure obesity, Ron DeSantis’s foreign policy doctrine (10:53) and why hype can help and hinder entrepreneurs (17:00).
This week’s worldwide cover celebrates the new drugs promising an end to the world’s obesity epidemic. They could bring riches for their makers, savings for health systems and better lives for millions.
Our new position paper with @worldheartfed summarises the relationship between obesity and cardiovascular disease (#CVD) mortality.
World Obesity Federation (January 2023) – The ongoing obesity epidemic represents a global public health crisis that contributes to poor health outcomes, reduced quality of life, and >2.8 million deaths each year. Obesity is relapsing, progressive, and heterogeneous. It is considered a chronic disease by the World Obesity Federation (WOF) and a chronic condition by the World Heart Federation (WHF).
People living with overweight/obesity are at greater risk for cardiovascular (CV) morbidity and mortality. Increased adiposity (body fat), particularly visceral/abdominal fat, is linked to CV risk and CV disease (CVD) via multiple direct and indirect pathophysiological mechanisms. The development of CVD is driven, in part, by obesity-related metabolic, endocrinologic, immunologic, structural, humoral, haemodynamic, and functional alterations.
Less than 7% of the U.S. adult population has good cardiometabolic health, a devastating health crisis requiring urgent action, according to research led by a team from @TuftsNutrition. https://t.co/fDnypaSwgS
— Tufts University (@TuftsUniversity) July 5, 2022
Less than 7% of the U.S. adult population has good cardiometabolic health, a devastating health crisis requiring urgent action, according to research led by a team from the Friedman School of Nutrition Science and Policy at Tufts University in a pioneering perspective on cardiometabolic health trends and disparities published in the July 12 issue of the Journal of the American College of Cardiology. Their team also included researchers from Tufts Medical Center.
Researchers evaluated Americans across five components of health: levels of blood pressure, blood sugar, blood cholesterol, adiposity (overweight and obesity), and presence or absence of cardiovascular disease (heart attack, stroke, etc.). They found that only 6.8 percent of U.S. adults had optimal levels of all five components as of 2017-2018.
Watch: Intermittent fasting can help improve focus and brain health for animals, studies show. We explain how some of these cognitive benefits can also apply to humans. https://t.co/msrfUFoTkn
Although intermittent fasting is most widely known as a weight-loss strategy, emerging research suggests that it could have benefits for brain health and cognition. But does it actually work, are there any drawbacks and how long would you have to fast to see benefits? WSJ’s Daniela Hernandez breaks down what’s known and what’s not about the neuroscience of intermittent fasting.
Timeline: 0:00 Could intermittent fasting help our brains work better and longer? 0:31 How long would you have to fast to see any potential cognitive benefits? 1:04 How intermittent fasting could affect your ability to focus 2:27 Potential mood-related benefits of intermittent fasting 2:48 How intermittent fasting can affect brain health 4:03 Potential drawbacks of intermittent fasting
Did you know that not getting enough zzz’s can actually make you hungrier? According to sleep scientist Matt Walker, the relationship between what you eat and your sleep is a two-way street. Here’s why understanding it can help you improve your overall health.
Sleep — we spend one-third of our lives doing it, but what exactly do we get out of it? And how can we do it better? In this TED series, sleep scientist Matt Walker uncovers the facts and secrets behind our nightly slumber. (Made possible with the support of Oura) Check out more episodes on TED.com: https://go.ted.com/sleepingwithscience
News, Views and Reviews For The Intellectually Curious